Market capitalization of Halozyme Therapeutics (HALO)

Market cap: A$9.87 Billion

As of October 2024 Halozyme Therapeutics has a market cap of A$9.87 Billion. This makes Halozyme Therapeutics the world's 2323th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of Halozyme Therapeutics was reported to be:

A$9.87 Billion

by Yahoo Finance

A$9.87 Billion

by CompaniesMarketCap

A$9.87 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
MannKind Corp MNKD	A$2.70 B	-72.59%	🇺🇸 USA
Eli Lilly LLY	A$1.230 T	12,369.17%	🇺🇸 USA
Baxter BAX	A$27.86 B	182.33%	🇺🇸 USA
Pfizer PFE	A$247.21 B	2,404.47%	🇺🇸 USA
Sanofi SNY	A$206.74 B	1,994.49%	🇫🇷 France
Johnson & Johnson JNJ	A$590.11 B	5,878.18%	🇺🇸 USA